Continuous prediction of secondary progression in the individual course of multiple sclerosis
Artikel i vetenskaplig tidskrift, 2014

Background: Prediction of the course of multiple sclerosis (MS) was traditionally based on features close to onset. Objective: To evaluate predictors of the individual risk of secondary progression (SP) identified at any time during relapsing-remitting MS. Methods: We analysed a database comprising an untreated MS incidence cohort (n=306) with five decades of follow-up. Data regarding predictors of all attacks (n=749) and demographics from patients (n=157) with at least one distinct second attack were included as covariates in a Poisson regression analysis with SP as outcome. Results: The average hazard function of transition to SPMS was 0.046 events per patient year, showing a maximum at age 33. Three covariates were significant predictors: age, a descriptor of the most recent relapse, and the interaction between the descriptor and time since the relapse. A hazard function termed "prediction score" estimated the risk of SP as number of transition events per patient year (range <0.01 to >0.15). Conclusions: The insights gained from this study are that the risk of transition to SP varies over time in individual patients, that the risk of SP is linked to previous relapses, that predictors in the later stages of the course are more effective than the traditional onset predictors, and that the number of potential predictors can be reduced to a few (three in this study) essential items. This advanced simplification facilitates adaption of the "prediction score" to other (more recent, benign or treated) materials, and allows for compact web-based applications

Secondary progression

Multiple sclerosis

Prediction

Prognosis

Continuous hazard function

Författare

Bengt Skoog

Göteborgs universitet

Helen Tedeholm

Göteborgs universitet

Björn Runmarker

Göteborgs universitet

Anders Odén

Chalmers, Matematiska vetenskaper, matematisk statistik

Göteborgs universitet

Oluf Andersen

Göteborgs universitet

Multiple Sclerosis and Related Disorders

2211-0348 (ISSN)

Vol. 3 584-592

Ämneskategorier

Klinisk medicin

DOI

10.1016/j.msard.2014.04.004